RxDoctor Payments DataLook up a doctor →

Jeffrey Rosen, MD

Internal Medicine · Coral Gables, FLNPI 1972555217

Payments from drug & device makers

$16,954,275in general payments, 2019–2025

Across 2,406 payments — averaging $7046.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$8.3M
  • AstraZeneca$2.5M
  • Merck$2.2M
  • Eli Lilly$718K
  • Sanofi US Services Inc.$488K
  • GSK$454K
  • plus $2.3M from 38 others
$118,739in research payments, 2019–2025

Across 20 payments — averaging $5936.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$74K
  • Valneva Austria GmbH$42K
  • Pfizer$2K
  • Sanofi US Services Inc.$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$16,954,275 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$48,772
Medicare patients
109
Services billed
640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Coral Gables

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →